Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

被引：0

作者：

M. Lefort

S. Sharmin

J. B. Andersen

S. Vukusic

R. Casey

M. Debouverie

G. Edan

J. Ciron

A. Ruet

J. De Sèze

E. Maillart

H. Zephir

P. Labauge

G. Defer

C. Lebrun-Frenay

T. Moreau

E. Berger

P. Clavelou

J. Pelletier

B. Stankoff

O. Gout

E. Thouvenot

O. Heinzlef

A. Al-Khedr

B. Bourre

O. Casez

P. Cabre

A. Montcuquet

A. Wahab

J. P. Camdessanché

A. Maurousset

H. Ben Nasr

K. Hankiewicz

C. Pottier

N. Maubeuge

D. Dimitri-Boulos

C. Nifle

D. A. Laplaud

D. Horakova

E. K. Havrdova

R. Alroughani

G. Izquierdo

S. Eichau

S. Ozakbas

F. Patti

M. Onofrj

A. Lugaresi

M. Terzi

P. Grammond

F. Grand’Maison

机构：

[1] Univ Rennes,Arènes

[2] EHESP, UMR 6051, RSMS (Recherche sur les Services et Management en Santé)

[3] CNRS, U 1309

[4] Inserm,Department of Medicine

[5] Univ Rennes,Melbourne MS Centre, Department of Neurology

[6] CHU Rennes,Department of Neurology

[7] Investigation Clinique de Rennes)],Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline Et Neuro

[8] University of Melbourne,Inflammation

[9] Royal Melbourne Hospital,Centre Des Neurosciences de Lyon, UMR5292

[10] The Danish Multiple Sclerosis Registry,Centre Hospitalier Régional Universitaire de Nancy

[11] Copenhagen University Hospital,Centre Hospitalier Universitaire de Rennes

[12] Hôpital Neurologique Pierre Wertheimer,Centre Hospitalier Universitaire de Toulouse

[13] Hospices Civils de Lyon,Centre Hospitalier Universitaire de Bordeaux

[14] Observatoire Français de La Sclérose en Plaques,Service des maladies inflammatoires du système nerveux – neurologie, centre d’investigation clinique de Strasbourg

[15] INSERM,Assistance Publique Des Hôpitaux de Paris

[16] Université,Centre Hospitalier Universitaire de Lille

[17] Claude Bernard Lyon 1,Centre Hospitalier Universitaire de Montpellier

[18] Faculté de médecine Lyon Est,Centre Hospitalier Universitaire de Caen Normandie

[19] Eugene Devic EDMUS Foundation,Centre Hospitalier Universitaire de Nice

[20] Hôpital Central,Centre Hospitalier Universitaire Dijon Bourgogne

[21] Hôpital Pontchaillou,Centre Hospitalier Régional Universitaire de Besançon

[22] Hôpital Purpan,Service de Neurologie

[23] CRC-SEP,Assistance Publique Des Hôpitaux de Paris

[24] Hôpital Pellegrin,Centre Hospitalier Universitaire de Martinique

[25] Hôpitaux Universitaire de Strasbourg,Centre Hospitalier Universitaire Limoges

[26] Hôpital de Hautepierre,Assistance Publique Des Hôpitaux de Paris

[27] Hôpital de La Pitié-Salpêtrière,Centre Hospitalier Universitaire de Poitiers

[28] Hôpital Salengro,Assistance Publique Des Hôpitaux de Paris

[29] Hôpital Gui de Chauliac,Centre Hospitalier de Versailles

[30] Hôpital Côte de Nacre,Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine

[31] UR2CA-URRIS,Division of Neurology, Department of Medicine

[32] ,GF Ingrassia Department

[33] Université Nice Côte d’Azur,Department of Neuroscience, Imaging, and Clinical Sciences

[34] Hôpital,Dipartimento Di Scienze Biomediche E Neuromotorie

[35] Hôpital François Mitterrand,Medical Faculty

[36] Maladies Inflammatoires du Système Nerveux Et Neurologie Générale,Nehme and Therese Tohme Multiple Sclerosis Center

[37] Hôpital Jean Minjoz,Department of Basic Medical Sciences, Neuroscience and Sense Organs

[38] Centre Hospitalier Universitaire de Clermont-Ferrand,School of Medicine and Public Health

[39] Hôpital Gabriel-Montpied,Department of Neurology

[40] Aix Marseille Univ,Department of Neuroscience

[41] APHM,Department of Medicine and Surgery

[42] Hôpital de La Timone,Department of Emergency and General Medicine

[43] Hôpital Saint-Antoine,Department of Neurology, Faculty of Medicine

[44] Fondation Adolphe de Rothschild de L’œil Et du Cerveau,Department of Clinical Epidemiology

[45] Centre Hospitalier Universitaire de Nîmes,Danish Multiple Sclerosis Centre, Department of Neurology

[46] Hôpital Carémeau,Department of Neurology

[47] Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye,Department of Neurology

[48] Centre Hospitalier Universitaire d’Amiens Picardie,Department of Clinical Medicine

[49] Rouen University Hospital,Department of Neurology

[50] Centre Hospitalier Universitaire Grenoble-Alpes,Central Clinical School

来源：

BMC Medical Research Methodology | / 22卷

关键词：

Effectiveness; Multiple sclerosis; Propensity score; Indication bias; Causal contrasts; Censoring; Positivity assumption;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
Lefort, M.
Sharmin, S.
Andersen, J. B.
Vukusic, S.
Casey, R.
Debouverie, M.
Edan, G.
Ciron, J.
Ruet, A.
De Seze, J.
Maillart, E.
Zephir, H.
Labauge, P.
Defer, G.
Lebrun-Frenay, C.
Moreau, T.
Berger, E.
Clavelou, P.
Pelletier, J.
Stankoff, B.
Gout, O.
Thouvenot, E.
Heinzlef, O.
Al-Khedr, A.
Bourre, B.
Casez, O.
Cabre, P.
Montcuquet, A.
Wahab, A.
Camdessanche, J. P.
Maurousset, A.
Ben Nasr, H.
Hankiewicz, K.
Pottier, C.
Maubeuge, N.
Nifle, C.
Laplaud, D. A.
Horakova, D.
Dimitri-Boulos, D.
Havrdova, E. K.
Alroughani, R.
Izquierdo, G.
Eichau, S.
Ozakbas, S.
Patti, F.
Onofrj, M.
Lugaresi, A.
Terzi, M.
Grammond, P.
Grand'Maison, F.
[J]. BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22 (01)
[2] Comparative effectiveness of natalizumab and fingolimod treatment on cognitive outcomes in relapsing multiple sclerosis patients
Iaffaldano, P.
Viterbo, R. G.
Lucisano, G.
Paolicelli, D.
Pippolo, L.
Baroncini, D.
Zaffaroni, M.
Ghezzi, A.
Trojano, M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 418 - 419
[3] Understanding heterogeneity in comparative effectiveness studies of natalizumab and fingolimod in multiple sclerosis: effect of analytical methodology
Lefort, M.
Shannin, S.
Andersen, J.
Vukusic, S.
Koch-Henriksen, N. J.
Lapland, D.
Butzkueven, H.
Magyari, M.
Kalincik, T.
Leray, E.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 342 - 342
[4] Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
Alping, Peter
Frisell, Thomas
Novakova, Lenka
Islam-Jakobsson, Protik
Salzer, Jonatan
Bjorck, Anna
Axelsson, Markus
Malmestrom, Clas
Fink, Katharina
Lycke, Jan
Svenningsson, Anders
Piehl, Fredrik
[J]. ANNALS OF NEUROLOGY, 2016, 79 (06) : 950 - 958
[5] Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis
Sharmin, S.
Lefort, M.
Andersen, J.
Horakova, D.
Havrdova, E. K.
Alroughani, R.
Izquierdo, G.
Eichau, S.
Ozakbas, S.
Butzkueven, H.
Patti, F.
Onofrj, M.
Lugaresi, A.
Terzi, M.
Grammond, P.
Grand'Maison, F.
Yamout, B.
Prat, A.
Girard, M.
Duquette, P.
Boz, C.
Trojano, M.
McCombe, P.
Slee, M.
Lechner-Scott, J.
Turkoglu, R.
Sola, P.
Ferraro, D.
Granella, F.
Shaygannejad, V.
Prevost, J.
Skibina, O.
Solaro, C.
Karabudak, R.
Van Wijmeersch, B.
Csepany, T.
Spitaleri, D.
Vucic, S.
Leray, E.
Sorensen, P. S.
Sellebjerg, F.
Magyari, M.
Vukusic, S.
Kalincik, T.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 786 - 788
[6] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Boz, Cavit
Ozakbas, Serkan
Terzi, Murat
Karabudak, Rana
Sevim, Serhan
Turkoglu, Recai
Soysal, Aysun
Balci, Belgin Petek
Efendi, Husnu
Turan, Omer Faruk
Yuceyar, Nur
Yetkin, Mehmet Fatih
Karahan, Serap Zengin
Demirkiran, Meltem
Guler, Sibel
Agan, Kadriye
Kiylioglu, Nefati
Baba, Cavid
Tuncer, Asli
Koseoglu, Mesrure
[J]. NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
[7] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
Cavit Boz
Serkan Ozakbas
Murat Terzi
Rana Karabudak
Serhan Sevim
Recai Turkoglu
Aysun Soysal
Belgin Petek Balcı
Hüsnü Efendi
Ömer Faruk Turan
Nur Yüceyar
Mehmet Fatih Yetkin
Serap Zengin Karahan
Meltem Demirkıran
Sibel Guler
Kadriye Agan
Nefati Kıylıoğlu
Cavid Baba
Asli Tuncer
Mesrure Köseoğlu
[J]. Neurological Sciences, 2023, 44 : 2121 - 2129
[8] Comparative effectiveness of natalizumab and fingolimod treatment on cognitive functions in relapsing multiple sclerosis
Iaffaldano, P.
Viterbo, R. G.
Lucisano, G.
Trojano, M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 687 - 687
[9] Comparative effectiveness in multiple sclerosis: A methodological comparison
Roos, Izanne
Diouf, Ibrahima
Sharmin, Sifat
Horakova, Dana
Havrdova, Eva Kubala
Patti, Francesco
Shaygannejad, Vahid
Ozakbas, Serkan
Izquierdo, Guillermo
Eichau, Sara
Onofrj, Marco
Lugaresi, Alessandra
Alroughani, Raed
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Terzi, Murat
Boz, Cavit
Grand'Maison, Francois
Sola, Patrizia
Ferraro, Diana
Grammond, Pierre
Turkoglu, Recai
Buzzard, Katherine
Skibina, Olga
Yamou, Bassem
Altintas, Ayse
Gerlach, Oliver
van Pesch, Vincent
Blanco, Yolanda
Maimone, Davide
Lechner-Scott, Jeannette
Bergamaschi, Roberto
Karabudak, Rana
McGuigan, Chris
Cartechini, Elisabetta
Barnett, Michael
Hughes, Stella
Sa, Maria Jose
Solaro, Claudio
Ramo-Tello, Cristina
Hodgkinson, Suzanne
Spitaleri, Daniele
Soysal, Aysun
Petersen, Thor
Granella, Franco
de Gans, Koen
McCombe, Pamela
Ampapa, Radek
Van Wijmeersch, Bart
[J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (03) : 326 - 332
[10] Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
Laplaud, D. A.
Barbin, L.
Rousseau, C.
Jousset, N.
Casey, R.
Debouverie, M.
Vukusic, S.
De Seze, J.
Brassat, D.
Wiertlewski, S.
Brochet, B.
Pelletier, J.
Vermersch, P.
Edan, G.
Lebrun-Frenay, C.
Clavelou, P.
Thouvenot, E.
Camdessanche, J. -P.
Tourbah, A.
Stankoff, B.
Al Khedr, A.
Cabre, P.
Papeix, C.
Berger, E.
Heinzlef, O.
Debroucker, T.
Moreau, T.
Gout, O.
Bourre, B.
Creange, A.
Labauge, P.
Magy, L.
Defer, G.
Foucher, Y.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 62 - 63

← 1 2 3 4 5 →